Grand Pharmaceutical Group Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

DB:MX6A Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
28 Jun 24	Buy€27,969	Weikun Tang	Individual	50,000	€0.56
20 Jun 24	Buy€62,876	Weikun Tang	Individual	110,000	€0.57
06 Jun 24	Buy€23,603	Chao Zhou	Individual	42,500	€0.56
24 May 24	Buy€31,896	Weikun Tang	Individual	56,000	€0.57
10 May 24	Buy€29,704	Chao Zhou	Individual	49,500	€0.60
09 May 24	Buy€58,036	Weikun Tang	Individual	100,000	€0.58
19 Apr 24	Buy€44,455	Weikun Tang	Individual	95,000	€0.47
08 Apr 24	Buy€46,988	Chao Zhou	Individual	101,000	€0.47
03 Apr 24	Buy€28,633	Weikun Tang	Individual	60,000	€0.48
26 Mar 24	Buy€48,100	Weikun Tang	Individual	100,000	€0.48
22 Mar 24	Buy€23,712	Chao Zhou	Individual	49,500	€0.48
21 Mar 24	Buy€26,810	Chao Zhou	Individual	56,500	€0.47
20 Mar 24	Buy€44,913	Weikun Tang	Individual	100,000	€0.45

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of MX6A?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	286,039,153	8.17%
Institutions	353,825,429	10.1%
VC/PE Firms	356,648,142	10.2%
General Public	790,267,275	22.6%
Individual Insiders	1,715,029,649	49%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 77.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
48.9%	Hu Kaijun	1,713,191,149	€942.1m	0%	no data
10.2%	CDH Investment Management Company Limited	356,648,142	€196.1m	0%	19.97%
8.17%	China Grand Enterprises Incorporation	286,039,153	€157.3m	0%	no data
2.84%	GL Capital Group	99,438,959	€54.7m	0%	37.01%
2.28%	Lion River I N.V.	79,735,000	€43.8m	0%	51.23%
1.53%	The Vanguard Group, Inc.	53,455,681	€29.4m	1.1%	no data
0.77%	Dimensional Fund Advisors LP	26,856,187	€14.8m	-0.02%	no data
0.73%	Bosera Asset Management Co., Ltd.	25,533,500	€14.0m	0%	0.06%
0.62%	GF Fund Management Co., Ltd.	21,842,000	€12.0m	0%	0.03%
0.59%	BlackRock, Inc.	20,758,027	€11.4m	0.83%	no data
0.12%	E Fund Management Co., Ltd.	4,100,000	€2.3m	0%	no data
0.11%	Principal Global Investors, LLC	3,940,500	€2.2m	-27.2%	no data
0.1%	State Street Global Advisors, Inc.	3,533,660	€1.9m	10.6%	no data
0.094%	American Century Investment Management Inc	3,297,979	€1.8m	18.7%	no data
0.035%	Charles Schwab Investment Management, Inc.	1,221,427	€671.7k	44.2%	no data
0.031%	PGIM, Inc.	1,092,500	€600.8k	0%	no data
0.027%	Teachers Insurance and Annuity Association-College Retirement Equities Fund	958,500	€527.1k	0%	no data
0.025%	China Southern Asset Management Co., Ltd.	877,500	€482.6k	0%	no data
0.024%	Yinhua Fund Management Co., Ltd.	856,000	€470.6k	0%	no data
0.024%	Penghua Fund Management Co., Ltd.	845,000	€464.7k	0%	no data
0.021%	Weikun Tang	731,000	€401.9k	0%	no data
0.02%	Geode Capital Management, LLC	686,039	€377.2k	-0.67%	no data
0.017%	Eaton Vance Management	608,500	€334.7k	0%	no data
0.017%	Chit Lam	579,000	€318.3k	0%	no data
0.014%	Ping An UOB Fund Management Co., Ltd.	490,500	€269.8k	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/01/20 16:50
End of Day Share Price	2025/01/17 00:00
Earnings	2024/06/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Grand Pharmaceutical Group Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yanyin Zhu	China International Capital Corporation Limited
Xiao Wei Lin	Everbright Securities Co. Ltd.
Yiling Chen	Guosen Securities Co., Ltd.